Association between acute kidney injury and long-term mortality in patients with aneurysmal subarachnoid hemorrhage: A retrospective study

Yangchun Xiao, Jun Wan, Yu Zhang, Xing Wang, Hanwen Zhou, Han Lai, Weelic Chong, Yang Hai, L. Dade Lunsford, Chao You, Shui Yu, Fang FangFrontiers in Neurology 2022 · DOI

TL;DR

This study reveals that acute kidney injury (AKI) during hospitalization for a brain aneurysm rupture (aSAH) is a significant predictor of death years later, even for patients who survive the first year. Crucially, the risk remains elevated even if the patient's kidney function appears to return to normal before they leave the hospital.

What Problem Does This Paper Address?

Aneurysmal subarachnoid hemorrhage (aSAH)—a type of stroke caused by a ruptured brain aneurysm—is a life-threatening event. While medical advances have improved short-term survival, those who make it past the first year still face a higher mortality rate than the general population.

One common complication during the initial hospital stay is Acute Kidney Injury (AKI), a sudden episode of kidney failure or damage. While we know AKI worsens immediate outcomes, its "long shadow" was previously unclear. Does a temporary hit to the kidneys during a brain crisis affect a patient's survival five or seven years down the line? This paper investigates whether AKI serves as a long-term prognostic marker for aSAH survivors.

Methods

The researchers conducted a retrospective cohort study at West China Hospital, analyzing data from 2,592 patients who survived at least 12 months after an aSAH event between 2013 and 2019.

  • Defining AKI: They used the KDIGO (Kidney Disease Improving Global Outcomes) guidelines, which categorize AKI into three stages based on changes in serum creatinine levels.
  • Tracking Mortality: To ensure high-quality data, they linked hospital records with the Chinese government’s Household Registration Administration System, providing a highly accurate record of deaths and minimizing "lost-to-follow-up" bias.
  • Statistical Rigor: Beyond standard Cox proportional hazards models, the team used propensity score matching to account for baseline differences between patients with and without AKI. They also calculated E-values to assess how robust their findings were against potential unmeasured confounding factors.

Datasets

The study utilized a large, single-center clinical dataset from West China Hospital, Sichuan University.

  • Size: 2,592 patients.
  • Follow-up: Median of 4.3 years, extending up to 7.3 years.
  • Validation: Mortality data was cross-referenced with a mandatory provincial death registry, which is more reliable than typical hospital-only follow-ups.

Key Insights and Ideas

  • The "Legacy Effect" of AKI: The most striking finding is that AKI isn't just a transient hurdle. It appears to leave a permanent mark on a patient’s health trajectory. Even a "Stage 1" (mild) AKI doubled the hazard ratio for long-term mortality.
  • Recovery is Deceptive: Traditionally, if a patient's creatinine levels return to baseline by discharge, the AKI is considered "resolved." However, this study found that these "recovered" patients still had nearly double the risk of death (HR 1.96) compared to those who never had AKI. This suggests that the initial injury might trigger chronic systemic inflammation or subclinical permanent nephron loss.
  • Dose-Response Relationship: There is a clear "more is worse" trend. As the severity of the AKI increased from Stage 1 to Stage 3, the risk of long-term mortality climbed progressively (HRs of 2.08, 2.15, and 2.66, respectively).

Key Results

  • Prevalence: 9.2% (238/2,592) of aSAH survivors experienced AKI during their initial hospitalization.
  • Mortality Risk: AKI was associated with a significantly higher risk of long-term death (Adjusted HR 2.13).
  • The Recovery Gap:
    • No AKI: Baseline risk.
  • AKI with Recovery: HR 1.96 (95% CI 1.40–2.74).
  • AKI without Recovery: HR 3.84 (calculated relative to the recovery group's better outcomes).
  • Sensitivity: The association remained significant even after adjusting for age, aneurysm size, Hunt and Hess grade (severity of the bleed), and treatment type (clipping vs. coiling).

Limitations and Future Work

  • Retrospective Nature: As an observational study, it can identify associations but cannot definitively prove that AKI causes the later deaths.
  • Missing Urine Data: The researchers relied solely on serum creatinine because daily urine output data was inconsistent. This might lead to an underestimation of the true AKI incidence.
  • Cause of Death: The study looked at all-cause mortality. Future research is needed to determine if these patients are dying specifically from renal failure, cardiovascular events, or other complications.
  • Single-Center: While the sample size is large, the data comes from one hospital system, which may limit generalizability to other healthcare settings or ethnicities.

The Bottom Line: For clinicians, this study suggests that a "normal" kidney function test at discharge doesn't mean the patient is in the clear. Long-term, multidisciplinary follow-up involving nephrologists may be necessary for any aSAH patient who suffered even a mild kidney injury during their stay.

Summary updated

Abstract

Among 12-month survivors of aSAH, AKI during their initial hospitalization for aSAH was associated with increased long-term mortality, even for patients who had normal renal function at the time of hospital discharge. Longer, multidisciplinary post-discharge follow-up may be warranted for these patients.
BibTeX
@inproceedings{xiao2022association,
  author = {Yangchun Xiao and Jun Wan and Yu Zhang and Xing Wang and Hanwen Zhou and Han Lai and Weelic Chong and Yang Hai and L. Dade Lunsford and Chao You and Shui Yu and Fang Fang},
  title = {{Association between acute kidney injury and long-term mortality in patients with aneurysmal subarachnoid hemorrhage: A retrospective study}},
  booktitle = {Frontiers in Neurology},
  year = {2022},
  doi = {10.3389/fneur.2022.864193},
}
Figure